In DMD patients, NF-κB activation induces fibrotic factors like TGF-β, leading to excessive deposition of fibrotic tissue that replaces functional muscle tissue, impairing muscle function and complicating the repair and regeneration process. The gene discussed is NFKB1; the disease is Duchenne muscular dystrophy.